Warfarin Toxicity and Individual Variability—Clinical Case
Warfarin is a widely used anticoagulant in the treatment and prevention of thrombosis, in the treatment for chronic atrial fibrillation, mechanical valves, pulmonary embolism, and dilated cardiomyopathy. It is tasteless and colorless, was used as a poison, and is still marketed as a pesticide agains...
Main Authors: | Steven Boyages, Colin Rochester, Trudi Jones, Irina Piatkov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-10-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/2/11/2584/ |
Similar Items
-
Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
by: Salih Kilic, et al.
Published: (2018-01-01) -
Identification of anticoagulation quality in patients using warfarin and associated factors
by: Lucas de Faria Martins Braga, et al.
Published: (2021-02-01) -
Management of warfarin complications in the emergency department
by: Mahmut Özdemir, et al.
Published: (2020-05-01) -
Risk of mortality between warfarin and direct oral anticoagulants: population-based cohort studies
by: Zixuan Wang, et al.
Published: (2024-12-01) -
The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
by: Salih Kılıç, et al.
Published: (2019-01-01)